Glaesner W - Search Results

1

Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions.

Darling RJ, Kuchibhotla U, Glaesner W, Micanovic R, Witcher DR, Beals JM. Darling RJ, et al. Among authors: glaesner w. Biochemistry. 2002 Dec 10;41(49):14524-31. doi: 10.1021/bi0265022. Biochemistry. 2002. PMID: 12463751

2

Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.

Glaesner W, Vick AM, Millican R, Ellis B, Tschang SH, Tian Y, Bokvist K, Brenner M, Koester A, Porksen N, Etgen G, Bumol T. Glaesner W, et al. Diabetes Metab Res Rev. 2010 May;26(4):287-96. doi: 10.1002/dmrr.1080. Diabetes Metab Res Rev. 2010. PMID: 20503261

3

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide.

Milicevic Z, Anglin G, Harper K, Konrad RJ, Skrivanek Z, Glaesner W, Karanikas CA, Mace K. Milicevic Z, et al. Among authors: glaesner w. Diabetes Obes Metab. 2016 May;18(5):533-6. doi: 10.1111/dom.12640. Epub 2016 Mar 4. Diabetes Obes Metab. 2016. PMID: 26847401 Clinical Trial.

4

A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog.

Saha JK, Xia J, Engle SK, Chen YF, Glaesner W, Jakubowski JA. Saha JK, et al. Among authors: glaesner w. J Pharmacol Exp Ther. 2006 Mar;316(3):1159-64. doi: 10.1124/jpet.105.093534. Epub 2005 Nov 9. J Pharmacol Exp Ther. 2006. PMID: 16280413

5

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.

Balasubramaniam D, Schroeder O, Russell AM, Fitchett JR, Austin AK, Beyer TP, Chen YQ, Day JW, Ehsani M, Heng AR, Zhen EY, Davies J, Glaesner W, Jones BE, Siegel RW, Qian YW, Konrad RJ. Balasubramaniam D, et al. Among authors: glaesner w. J Lipid Res. 2022 May;63(5):100198. doi: 10.1016/j.jlr.2022.100198. Epub 2022 Mar 17. J Lipid Res. 2022. PMID: 35307397 Free PMC article.

6

[Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)].

Tamaki C, Takeuchi M, Iwamoto N, Glaesner W. Tamaki C, et al. Among authors: glaesner w. Nihon Yakurigaku Zasshi. 2015 Oct;146(4):215-24. doi: 10.1254/fpj.146.215. Nihon Yakurigaku Zasshi. 2015. PMID: 26656966 Review. Japanese. No abstract available.

7

Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care?

Mallbris L, Davies J, Glasebrook A, Tang Y, Glaesner W, Nickoloff BJ. Mallbris L, et al. Among authors: glaesner w. J Clin Aesthet Dermatol. 2016 Jul;9(7):13-5. Epub 2016 Jul 1. J Clin Aesthet Dermatol. 2016. PMID: 27672407 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters